GOSS Reports $136.9M Cash, $48.9M R&D, Pauses PH-ILD Study, Seeks FDA Meeting
Gossamer Bio, Inc. Common Stock · Now $0.20
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS